Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases

This study is ongoing, but not recruiting participants.

Sponsored by:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00140985

Purpose

Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.

Condition	Intervention	Phase
Renal Disorder	Drug: MK0954, losartan potassium/Duration of Treatment: 20 weeks Drug: Comparator: amlodipine / Duration of Treatment: 20 weeks	Phase IV

Drug Information available for: Losartan Losartan potassium Amlodipine Amlodipine besylate Potassium chloride

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title:	Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases

Further study details as provided by Merck:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:	98
Study Start Date:	January 2000

Eligibility

Criteria

Inclusion Criteria:

Males or females at least 18 years of age with non-diabetic proteinuric renal diseases

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00140985

Locations

Spain
Merck Sharp & Dohme De Espana, S.A.E.
Madrid, Spain, 28027

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

Study ID Numbers:	2005_058
Study First Received:	August 30, 2005
Last Updated:	October 25, 2005
ClinicalTrials.gov Identifier:	NCT00140985
Health Authority:	Spain: Ministry of Health

Study placed in the following topic categories:

Losartan
Urologic Diseases
Kidney Diseases
Angiotensin II
Amlodipine

Additional relevant MeSH terms:

Angiotensin II Type 1 Receptor Blockers
Molecular Mechanisms of Pharmacological Action
Therapeutic Uses
Cardiovascular Agents

Anti-Arrhythmia Agents
Antihypertensive Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 13, 2009